Stay updated on CA-4948 in CNS Lymphoma: Clinical Trial

Sign up to get notified when there's something new on the CA-4948 in CNS Lymphoma: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CA-4948 in CNS Lymphoma: Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    0.7%
    Check dated 2025-06-20T04:48:42.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The page has been updated to reflect the latest version as v2.16.3, replacing the previous version v2.16.2. The estimated last update posted has been removed.
    Difference
    0.1%
    Check dated 2025-06-13T00:54:22.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new clinical trial version and the addition of a new physician, Ahmed Hamdy, MD, while removing the previous version's details and the name of Catherine Wang, MD.
    Difference
    1%
    Check dated 2025-06-05T20:50:38.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-29T15:40:44.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T01:45:40.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect the closure of enrollment for Parts A1 and A2 of the clinical trial evaluating emavusertib, and it now includes detailed descriptions of the trial's structure, including the non-randomized and randomized components of Parts B and C.
    Difference
    31%
    Check dated 2025-04-16T14:09:42.000Z thumbnail image

Stay in the know with updates to CA-4948 in CNS Lymphoma: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CA-4948 in CNS Lymphoma: Clinical Trial page.